Statins × blood pressure

TrialBMJ open2018

Informed shared decision-making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial.

Susanne Buhse et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 363 people · 2018

Randomised comparison

Probably raised blood pressure

17×4.4× to 63×

Bigger than almost all on the map

As reported

OR 16.6, 95% CI 4.40–63.0

Randomised comparison

Probably raised blood pressure

22×5.3× to 93×

Bigger than almost all on the map

As reported

OR 22.2, 95% CI 5.30–93.3

Randomised comparison

Probably raised blood pressure

26×6.5× to 105×

Bigger than almost all on the map

As reported

OR 26.0, 95% CI 6.50–105

Not counted

Probably raised quality of life & behaviour

+4.06+2.96 to +5.17

As reported

difference 4.06, 95% CI 2.96–5.17

Four numbers in the abstract

the abstract, start to end

regarding statin intake, 34% vs 3%, OR 16.6 (95% CI 4.4 to 63.0), blood pressure control, 39% vs 3%, OR 22.2 (95% CI 5.3 to 93.3) and glycated haemoglobin, 43% vs 3%, OR 26.0 (95% CI 6.5 to 104.8).

a mean score of 6.96 vs 2.86, difference 4.06 (95% CI 2.96 to 5.17).

← favours treatmentfavours comparator →
could be chance
Blood pressure
OR 16.64.40–63.0
Blood pressure
OR 22.25.30–93.3
Blood pressure
OR 26.06.50–105
Quality of life & behaviour
4.062.96–5.17
StatinsAntihypertensivesBlood pressureQuality of life & behaviour

Statins × blood pressurehelps?replicated

unlikelylikely
0.831.00 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 6

11 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30552272